SAN DIEGO, Calif. — NanoCellect Biomedical Inc. (“NanoCellect”), the market-leading provider of microfluidic cell sorting solutions to advance cellular discoveries announced the close of $35M of financing to further accelerate commercial growth plans and new product development goals. “The past 18 months have been challenging given the ongoing pandemic, but our WOLF Pack completed the development and […]

MINNEAPOLIS — Flywheel, the leading biomedical research data management platform, today announces a $22 million Series C funding round, with more financing expected in the coming weeks, as investors show continued confidence in the company’s growth and market impact. The Series C funding supported Flywheel’s recent acquisition of Radiologics. (Graphic: Shutterstock) The funding round is […]

BOSTON — Seven Bridges, the industry-leading bioinformatics ecosystem provider, and Scripps Research have been awarded a $7.5M contract to develop a federated data ecosystem for the National Institute of Allergy and Infectious Diseases (NIAID) under a project titled the NIAID Data Ecosystem (NDE). The NDE will be a secure environment to find, access, query and analyze data from select NIAID repositories, […]

Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and existing investors. The funding will drive the commercialization and applications for the Company’s new Orion spatial biology platform and further global expansion […]

Fremont, CA — Alamar Biosciences, Inc., a precision proteomics company that brings both ultra-high sensitivity and massively parallel scale to proteomic analysis, announced today that it has closed its $80 million Series B financing round, bringing its total funding to $110 million. The Series B financing round was led by Sherpa Healthcare Partners and included […]

Company plans to expand research and development and scale commercial organization to support global customer base  BOSTON, MA — Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 million to date. “This […]

BARCELONA — Today, Seqera Labs – the leading provider of data orchestration and workflow software for life sciences – announces it has raised $5.5 million USD in seed funding. The round was co-led by European VCs Talis Capital and Speedinvest, with participation from existing investor BoxOne Ventures. The funding also includes a grant from the […]

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: John Marotta) has today announced the approval by Tokyo Stock Exchange, Inc. (the “TSE”) for the listing of the shares of its common stock (the “shares”) on the First Section of TSE. The scheduled date for the listing of the shares is Thursday October 14, […]

WOBURN, MA — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the pricing of its initial public offering of 3,060,000 shares of its common stock and accompanying warrants to purchase up […]

The new approach will be tested in three cohorts of patients diagnosed with Cystic Fibrosis, Alzheimer’s Disease, and Coronary Artery Disease ATLANTA, GA, UNITED STATES — Sequegenics today announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $251,073 to conduct research and development (R&D) work on a new approach […]